Jason Dinges

President at Pinteon Therapeutics.

Earliest Form D on file: Nov 2025

Filed Nov 12, 2025Amendment

Pinteon Therapeutics

Antibody against toxic tau for brain injury and Alzheimer's

Biotech, Newton Centre MA

Signed as President

$29.2M

sold of $32.1M offered

Reported on an amendment to an earlier filing.

Network

At Pinteon Therapeutics

1 person

Westley Nolin
Director